OPKO Health is a diverse healthcare company focused on improving patient lives.
Location: United States, Florida, Miami
Investors 1
| Date | Name | Website |
| - | BioAdvance | bioadvance... |
Mentions in press and media 15
| Date | Title | Description |
| 16.06.2026 | Oral Osteoporosis Drug Clears Key PK Test: Pill Matching Forteo Heads to Phase 3 Trial | By Maxwell Templeton Published: Jun 16 2026, 13:10 PM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 12.11.2025 | Laboratory Economics Issues Research Report on U.S. Anatomic Pathology Market | Laboratory Economics has just published the most comprehensive and detailed market research report available on the U.S. Anatomic Pathology Market. This is an ideal resource for preparing business plans and market strategies. POUGHKEEPSIE, ... |
| 30.12.2024 | 3 Stocks That Wall Street Insiders Can’t Stop Buying Insider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are... | Insider activity is hot in names like Vestis (NYSE: VSTS), OPKO Health (NASDAQ: OPK), and Greif, Inc. (NYSE: GEF), and investors should take notice. From board members to CEOs, CFOs, and other corporate officers, insiders are buying these ... |
| 08.03.2024 | Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates | JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial results and key business updates for the fourth qua... |
| 13.03.2023 | Digital health news, funding round up in the prior week; March 13, 2023 | WeightWatchers bought Sequence; Volastra Therapeutics raised $60M; Instacart partnered with PHA Top Health News Novant Health, a network of hospitals, physician clinics and outpatient facilities in North Carolina, South Carolina and Georgia... |
| 21.10.2022 | As links to MS deepen, researchers accelerate efforts to develop an Epstein-Barr vaccine | Maybe you’ve never heard of the Epstein-Barr virus. But it knows all about you. Chances are, it’s living inside you right now. About 95% of American adults are infected sometime in their lives. And once infected, the virus stays ... |
| 16.05.2022 | Digital health news, funding roundup in the prior week; May 16, 2022 | $3.1B to fight COVID globally; Academy partnered with Nuance; Vida launched prescription service Top Health News Vida Health, which provides a collaborative care model that provides access to practitioners including coaches, licensed therap... |
| 11.06.2015 | EirGen Founders To Share €30m | Two pharmaceutical executives who quit their multinational employer ten years ago to establish EirGen Pharma in Waterford are in the money after the company was taken over by NYSE-listed Opko Health. Opko, based in Miami, is paying $100m ca... |
| 10.02.2015 | Looks like BioVentures is in the midst of raising a new $100M fund | The venture firm typically invests $3 million to $10 million, it says, and does operate like your typical VC, however: “Generally, we like to see a business plan that calls for total capital requirement of $15 million to $20 million to reac... |
| 15.11.2013 | “Biobetters” startup based on drug discovery tech from Scripps lands $9 million | According to OPKO Health (NYSE:OPK), which said last month it was making an undisclosed strategic investment in the company, Zebra’s platform is an advanced version of a core technology that was crucial to the discovery of AbbVie’s Humira, ... |
Show more